http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2015137121-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-067 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate | 2015-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2015137121-A1 |
| titleOfInvention | Ribonucleoside analogs having an azide group, process for producing the same, and chimeric oligoribonucleotide analogs containing triazole-linked oligoribonucleotides formed from the analogs |
| abstract | A method for producing a non-natural nucleoside analog in which the 5-position is a hydroxyl group for synthesizing a triazole-linked non-natural nucleotide containing a structure linked through an organic group containing a 1,2,3-triazole ring. provide. The present invention provides a compound of formula (Ic): [Where: Each X is independently selected from a purine base and a pyrimidine base; PG 2 and PG 5 are each independently hydrogen or a protecting group] A process for producing a compound represented by The present invention relates to the above-mentioned method, comprising using D-xylose as a starting material, 3β-azidation of 3α-hydroxyl of D-xylose, and binding a purine base or pyrimidine base at the 1-position. |
| priorityDate | 2014-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 147.